A series of 13 acyclic nucleoside phosphonates (ANPs) as bisamidate prodrugs was prepared. Five compounds were found to be non-cytotoxic and selective inhibitors of Bordetella pertussis adenylate cyclase toxin (ACT) in J774A.1 macrophage cell-based assays. The 8-aza-7-deazapurine derivative of adefovir (PMEA) was found to be the most potent ACT inhibitor in the series (IC50 =16 nm) with substantial selectivity over mammalian adenylate cyclases (mACs). AC inhibitory properties of the most potent analogues were confirmed by direct evaluation of the corresponding phosphonodiphosphates in cell-free assays and were found to be potent inhibitors of both ACT and edema factor (EF) from Bacillus anthracis (IC50 values ranging from 0.5 to 21 nm). Moreover, 7-halo-7-deazapurine analogues of PMEA were discovered to be potent and selective mammalian AC1 inhibitors (no inhibition of AC2 and AC5) with IC50 values ranging from 4.1 to 5.6 μm in HEK293 cell-based assays.

Department of Medicinal Chemistry and Molecular Pharmacology College of Pharmacy Purdue University 575 Stadium Mall Drive West Lafayette IN 47907 USA

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Flemingovo nám 2 16610 Prague 6 Czech Republic

Zobrazit více v PubMed

Friedman RL, Nordensson K, Wilson L, Akporiaye ET, Yocum DE, Infect. Immun 1992, 60, 4578–4585. PubMed PMC

Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW, Lancet Infect. Dis 2017, 17, 974–980. PubMed

Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM, Wu KK-H, Goldsmith CS, Greer PW, Montague JL, Eliason MT, Holman RC, Guarner J, Shieh W-JW, Zaki SR, Clin. Infect. Dis 2008, 47, 328–338. PubMed

Kilgore PE, Salim AM, Zervos MJ, Schmitt H-J, Clin. Microbiol. Rev 2016, 29, 449–486. PubMed PMC

Tiwari T, Murphy TV, Moran J, Morb. Mortal. Wkly. Rep 2005, 54, 1–16. PubMed

Wood N, McIntyre P, Paediatr. Respir. Rev 2008, 9, 201–212. PubMed

Bartkus JM, Juni BA, Ehresmann K, Miller CA, Sanden GN, Cassiday PK, Saubolle M, Lee B, Long J, Harrison AR, Besser JM, J. Clin. Microbiol 2003, 41, 1167–1172. PubMed PMC

Davies J, Davies D, Microbiol. Mol. Biol. Rev 2010, 74, 417–433. PubMed PMC

Weiss AA, Hewlett EL, Myers GA, Falkow S, J. Infect. Dis 1984, 150, 219–222. PubMed

Carbonetti NH, Future Microbiol 2010, 5, 455–469. PubMed PMC

Fedele G, Bianco M, Ausiello CM, Archivum Immunologiae et Therapiae Experimentalis 2013, 445–457. PubMed

Weiss AA, Mary GMS, Infect. Immun 1989, 57, 3757–3764. PubMed PMC

Goodwin MSM, Weiss AA, Infect. Immun 1990, 58, 3445–3447. PubMed PMC

Gross MK, Au DC, Smith AL, Storm DR, Proc. Natl. Acad. Sci. U. S. A 1992, 89, 4898–4902. PubMed PMC

Bumba L, Masin J, Fiser R, Sebo P, PLoS Pathog 2010, 6, 1–15. PubMed PMC

Basler M, Knapp O, Masin J, Fiser R, Maier E, Benz R, Sebo P, Osicka R, J. Biol. Chem 2007, 282, 12419–12429. PubMed

Osičková A, Osička R, Maier E, Benz R, Šebo P, J. Biol. Chem 1999, 274, 37644–37650. PubMed

Ladant D, Ullmann A, Trends Microbiol 1999, 172–176. PubMed

Vojtova J, Kamanova J, Sebo P, Curr. Opin. Microbiol 2006, 9, 69–75. PubMed

Shrivastava R, Miller JF, Curr. Opin. Microbiol 2009, 12, 88–93. PubMed PMC

Confer D, Eaton J, Science 1982, 217, 948–950. PubMed

Friedman RL, Fiederlein RL, Glasser L, Galgiani JN, Infect. Immun 1987, 55, 135–140. PubMed PMC

Pearson RD, Symes P, Conboy M, Weiss AA, Hewlett EL, J. Immunol 1987, 139, 2749–2754. PubMed

Weingart CL, Weiss AA, Society 2000, 68, 1735–1739. PubMed PMC

Ross PJ, Lavelle EC, Mills KHG, Boyd AP, Infect. Immun 2004, 72, 1568–1579. PubMed PMC

Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, Ausiello CM, Infect. Immun 2006, 74, 2831–2838. PubMed PMC

De Clercq E, Holý A, Rosenberg I, Sakuma T, Balzatini J, Maudgal PC, Nature 1986, 323, 464–467. PubMed

De Clercq E, Holý A, Nat. Rev. Drug Discov 2005, 4, 928–940. PubMed

Reiser H, Wang J, Chong L, Watkins WJ, Ray AS, Shibata R, Birkus G, Cihlar T, Wu S, Li B, Liu X, Henne LN, Wolfgang GHI, Desai M, Rhodes GR, Fridland A, Lee WA, Plunkett W, Vail D, Thamm DH, Jeraj R, Tumas DB, Clin. Cancer Res 2008, 14, 2824–2832. PubMed

Zídek Z, Potměšil P, Holý A, Toxicol. Appl. Pharmacol 2003, 192, 246–253. PubMed

Česnek M, Hocková D, Holý A, Dračínský M, Baszczyňski O, De Jersey J, Keough DT, Guddat LW, Bioorg. Med. Chem 2012, 20, 1076–1089. PubMed

Keough DT, Hocková D, Holý A, Naesens LMJ, Skinner-Adams TS, De Jersey J, Guddat LW, J. Med. Chem 2009, 52, 4391–4399. PubMed

Hocková D, Keough DT, Janeba Z, Wang TH, De Jersey J, Guddat LW, J. Med. Chem 2012, 55, 6209–6223. PubMed

Keough DT, Špaček P, Hocková D, Tichý T, Vrbková S, Slavětínká L, Janeba Z, Naesens L, Edstein MD, Chavchich M, Wang TH, De Jersey J, Guddat LW, J. Med. Chem 2013, 56, 2513–2526. PubMed

Keough DT, Hocková D, Janeba Z, Wang TH, Naesens L, Edstein MD, Chavchich M, Guddat LW, J. Med. Chem 2015, 58, 827–846. PubMed

Keough DT, Hocková D, Rejman D, Špaček P, Vrbková S, Krečmerová M, Eng WS, Jans H, West NP, Naesens LMJ, De Jersey J, Guddat LW, J. Med. Chem 2013, 56, 6967–6984. PubMed

Česnek M, Holý A, Masojídková M, Kmoníčková E, Zídek Z, Bioorg. Med. Chem 2008, 16, 965–980. PubMed

Zídek Z, Franková D, Holý A, Antimicrob. Agents Chemother 2001, 45, 3381–3386. PubMed PMC

Zídek Z, Franková D, Holý A, Int. J. Immunopharmacol 2000, 22, 1121–1129. PubMed

Potměšil P, Krečmerová M, Kmoníčková E, Holý A, Zídek Z, Eur. J. Pharmacol 2006, 540, 191–199. PubMed

Guo Q, Shen Y, Lee Y-S, Gibbs CS, Mrksich M, Tang W-J, EMBO J 2005, 24, 3190–3201. PubMed PMC

Shen Y, Zhukovskaya NL, Zimmer MI, Soelaiman S, Bergson P, Wang C-R, Gibbs CS, Tang W-J, Proc. Natl. Acad. Sci. U. S. A 2004, 101, 3242–3247. PubMed PMC

Šmídková M, Dvořáková A, Tloust’ová E, Česnek M, Janeba Z, Mertlíková-Kaiserová H, Antimicrob. Agents Chemother 2014, 58, 664–671. PubMed PMC

Česnek M, Jansa P, Šmídková M, Mertlíková-Kaiserová H, Dračínský M, Brust TF, Pávek P, Trejtnar F, Watts VJ, Janeba Z, ChemMedChem 2015, 10, 1351–1364. PubMed

Göttle M, Dove S, Steindel P, Shen Y, Tang W-J, Geduhn J, König B, Seifert R, Mol. Pharmacol 2007, 72, 526–535. PubMed

Dvořáková H, Holý A, Snoeck R, Balzarini J, De Clercq E, Collect. Czech. Chem. Commun 1990, 55, S113–S116.

Dvořáková H, Holý A, Collect. Czech. Chem. Commun 1993, 58, 1419–1429.

Jansa P, Baszczyňski O, Dračínský M, Votruba I, Zídek Z, Bahador G, Stepan G, Cihlar T, Mackman R, Holý A, Janeba Z, Eur. J. Med. Chem 2011, 46, 3748–3754. PubMed

Holý A, Günter J, Dvořáková H, Masojídková M, Andrei G, Snoeck R, Balzarini J, De Clercq E, J. Med. Chem 1999, 42, 2064–2086. PubMed

Kaiser MM, Baszczyňski O, Hocková D, Poštová-Slavětínská L, Dračínský M, Keough DT, Guddat LW, Janeba Z, ChemMedChem 2017, 12, 1133–1141. PubMed

Bambuch V, Otmar M, Pohl R, Masojídková M, Holý A, Tetrahedron 2007, 63, 1589–1601.

Herdewijn P, Česnek M, Heterocycles 2010, 82, 663–687.

Jansa P, Baszczyňski O, Procházková E, Dračínský M, Janeba Z, Green Chem 2012, 14, 2282–2288.

Holý A, Rosenberg I, Dvořáková H, Collect. Czech. Chem. Commun 1989, 54, 2190–2210.

Holý A, Dvořáková H, Jindřich J, Masojídková M, Buděšínský M, Balzarini J, Andrei G, De Clercq E, J. Med. Chem 1996, 39, 4073–4088. PubMed

Holý A, Rosenberg I, Collect. Czech. Chem. Commun 1987, 52, 2801–2809.

Frydrych J, Skácel J, Šmídková M, Mertlíková-Kaiserová H, Dračínský M, Gnanasekaran R, Lepšík M, Soto-Velasquez M, Watts VJ, Janeba Z, ChemMedChem 2018, 13, 199–206. PubMed

Wang H, Xu H, Wu LJ, Kim SS, Chen T, Koga K, Descalzi G, Gong B, Vadakkan KI, Zhang X, Kaang BK, Zhuo M, Sci. Transl. Med 2011, 3, 65ra3. PubMed

Brust TF, Alongkronrusmee D, Soto-Velasquez M, Baldwin TA, Ye Z, Dai M, Dessauer CW, van Rijn RM, Watts VJ, Sci. Signal 2017, 10, eaah5381. PubMed PMC

Klečka M, Pohl R, Čejka J, Hocek M, Org. Biomol. Chem 2013, 11, 5189–5193. PubMed

Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir

Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects

Halogen-Dance-Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2-Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases

Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases